Lone Star Funds
—
SectorsHealthcare2Industrial1
RegionsEU2
Last activity
Activity, last 12 months
| Month | Events |
|---|---|
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 1 |
| April 2026 | 1 |
| May 2026 | 0 |
| June 2026 | 1 |
| July 2026 | 0 |
Deal history
Lone Star to buy Lonza capsules unit for EUR 1.5bn
Lone Star Funds has agreed to acquire Lonza Group AG’s capsules and health ingredients business for EUR 1.5 billion. Financing work is under way, with a debt package reported to be in market.
Lone Star buys Lonza CHI in EUR 2.78bn carve-out
Lone Star Funds has agreed to acquire Lonza Capsules and Health Ingredients (CHI) for EUR 2.78 billion, backing the unit as Lonza completes its pivot to a pure-play CDMO.